Bullish option flow detected in Apellis Pharmaceuticals with 6,905 calls trading, 3x expected, and implied vol increasing almost 2 points to 106.35%. Oct-23 40 calls and Oct-23 60 calls are the most active options, with total volume in those strikes near 2,500 contracts. The Put/Call Ratio is 0.26. Earnings are expected on November 6th.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on APLS:
- Apellis price target raised to $46 from $44 at BofA
- ‘There’s Good Value in the Market Now’: J.P. Morgan Suggests 2 Stocks to Buy — Including One With 80% Upside
- Biotech Alert: Searches spiking for these stocks today
- JP Morgan Upgrades Apellis (NASDAQ:APLS) after Impressive Q3 Results
- Apellis price target raised to $44 from $43 at BofA